Interpace Biosciences Inc
OTC:IDXG
Interpace Biosciences Inc
Selling, General & Administrative
Interpace Biosciences Inc
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Interpace Biosciences Inc
OTC:IDXG
|
Selling, General & Administrative
-$19.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
|
DaVita Inc
NYSE:DVA
|
Selling, General & Administrative
-$1.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Selling, General & Administrative
-$1.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
|
CVS Health Corp
NYSE:CVS
|
Selling, General & Administrative
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cigna Corp
NYSE:CI
|
Selling, General & Administrative
-$14.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Selling, General & Administrative
-$2.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-6%
|
See Also
What is Interpace Biosciences Inc's Selling, General & Administrative?
Selling, General & Administrative
-19.6m
USD
Based on the financial report for Dec 31, 2023, Interpace Biosciences Inc's Selling, General & Administrative amounts to -19.6m USD.
What is Interpace Biosciences Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
2%
Over the last year, the Selling, General & Administrative growth was 3%. The average annual Selling, General & Administrative growth rates for Interpace Biosciences Inc have been 13% over the past three years , -3% over the past five years , and 2% over the past ten years .